First Edition, July 2009
Trainers’ Manual
Recommendations for a public health approach
2010 revision
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Externalising disorders
Chapter D.3
Master of Science in Pharmaceutical Management Dissertation
National Tuberclosis and
Leprosy Programme (NTLP)
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to... patients. This guideline addresses specifically the issues on what to report, why to report, when to report, where to report and how to report.
more
Document No. : FDA/SMC/CTD/GL-CCT/2013/01